PhaseBio Pharmaceuticals, Inc.
USD0.07
+0.00 (+0.00%)
CEO
Jonathan Mow
IPO Date
2018-10-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.08
Prev. Close
$0.07
Day Low
$0.07
Day High
$0.09
52W Low
$0.04
52W High
$4.08
Volume
8.60M
| -1.0 |
| 31 Dec 2019 | FY | 100.0% | -1662.3% | -65.4% | -47.6% | 0.25 | 9.30 | -4.3 |
| 31 Dec 2018 | FY | 100.0% | -3569.8% | -46.8% | -37.8% | 0.15 | 13.68 | -0.7 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 10.5% | -72.7% | -0.16 | 0.78 | -5.5 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 10.6% | -223.9% | 0.00 | 4.60 | -6.7 |
| -1.4 |
| 31 Dec 2021 | Q4 | 100.0% | 55588.6% | -94.4% | 145.1% | -0.08 | 1.75 | 0.4 |
| 30 Sept 2021 | Q3 | 100.0% | -9529.6% | 63.4% | -41.1% | -0.19 | 3.04 | -1.2 |
| 30 Jun 2021 | Q2 | 100.0% | -277.4% | 149.6% | -28.5% | -0.59 | 5.47 | -1.6 |
| 31 Mar 2021 | Q1 | 0.0% | 0.0% | -325.3% | -27.1% | 1.51 | 5.29 | -1.0 |
| 31 Dec 2020 | Q4 | 100.0% | -9492187500000000.0% | 120.5% | -60.3% | -0.48 | 2.68 | -0.8 |
| 30 Sept 2020 | Q3 | 100.0% | -10432.8% | -577.7% | -43.2% | 3.09 | 4.39 | -1.0 |
| 30 Jun 2020 | Q2 | 100.0% | -4003.1% | -106.6% | -39.7% | 0.56 | 3.58 | -1.2 |
| 31 Mar 2020 | Q1 | 100.0% | -4657.8% | -27.9% | -19.4% | 0.28 | 9.68 | -1.6 |